- Review
120 Views
8 Pages
Cardiovascular Drug Interactions with Tyrosine Kinase Inhibitors
- Amina Haouala,
- Nicolas Widmer,
- Michael Montemurro,
- Thierry Buclin and
- Laurent Decosterd
Imatinib mesylate, a selective inhibitor of tyrosine kinases, has excellent efficacy in the treatment of chronic myeloid leukaemia (CML) and gastrointestinal stromal tumour (GIST). Inducing durable responses and achieving prolonged survival, it has b...